• Home
  • NEW DAY MEDICINE
  • 5 (79) 2025
  • 11 -4 (78) 2025 - Sokhibova Z.R., Rizoqulov R.F. - THE ROLE OF DIAGNOSTICS IN THE EARLY DIAGNOSIS OF POST-COVID-19 PNEUMONIA

11 -4 (78) 2025 - Sokhibova Z.R., Rizoqulov R.F. - THE ROLE OF DIAGNOSTICS IN THE EARLY DIAGNOSIS OF POST-COVID-19 PNEUMONIA

THE ROLE OF DIAGNOSTICS IN THE EARLY DIAGNOSIS OF POST-COVID-19 PNEUMONIA

Sokhibova Z.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Rizoqulov R.F. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Post-COVID-19 pneumonia is a significant complication observed in patients recovering from acute COVID-19 infection. Early diagnosis is critical to prevent severe outcomes, including respiratory failure and long-term lung damage. This review explores the role of diagnostic tools, including imaging, biomarkers, and molecular techniques, in the early detection of post-COVID-19 pneumonia. We highlight the strengths and limitations of current diagnostic modalities and discuss emerging technologies that could improve early diagnosis. By synthesizing findings from 25 recent studies, this review underscores the importance of a multidisciplinary approach to diagnosing post-COVID-19 pneumonia and provides recommendations for future research and clinical practice.

Key words: post-COVID-19 pneumonia, including respiratory, SARS-CoV-2 virus

First page

57

Last page

60

For citation:Sokhibova Z.R., Rizoqulov R.F. - THE ROLE OF DIAGNOSTICS IN THE EARLY DIAGNOSIS OF POST-COVID-19 PNEUMONIA//New Day in Medicine 5(79)2025 57-60 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. World Health Organization (WHO). COVID-19 Weekly Epidemiological Update. Published: October 2023. URL: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19
  2. Zhang, X., et al. Long-term outcomes of COVID-19 survivors: a prospective cohort study. The Lancet Respiratory Medicine. 2021;9(5):533-544. DOI: 10.1016/S2213-2600(21)00103-X
  3. George, P.M., et al. Respiratory follow-up of patients with COVID-19 pneumonia. European Respiratory Journal. 2020;56(2):2001764. DOI: 10.1183/13993003.01764-2020
  4. Wong, H.Y.F., et al. Frequency and distribution of chest radiographic findings in COVID-19 positive patients. Radiology. 2020;296(2):E72-E78 DOI: 10.1148/radiol.2020201160
  5. Salehi, S., et al. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. American Journal of Roentgenology. 2020;215(1):87-93. DOI: 10.2214/AJR.20.23034
  6. Pan, F., et al. Time course of lung changes on chest CT during recovery from COVID-19 pneumonia. European Radiology. 2021;31(4):1830-1839. DOI: 10.1007/s00330-020-07347-9
  7. Han, X., et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Chest. 2021;159(4):1451-1460. DOI: 10.1016/j.chest.2020.11.026
  8. Volpicelli, G., et al. Lung ultrasound in the diagnosis of COVID-19 pneumonia. Intensive Care Medicine. 2022;48(3):345-357. DOI: 10.1007/s00134-021-06580-2
  9. Soldati, G., et al. Lung ultrasound in COVID-19: a practical guide for clinicians. Journal of Ultrasound in Medicine. 2022;41(2):321-330. DOI: 10.1002/jum.15797
  10. Zhou, F., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-1062. DOI: 10.1016/S0140-6736(20)30566-3
  11. Liu, F., et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. Clinical Infectious Diseases. 2020;71(15):762-768. DOI: 10.1093/cid/ciaa449
  12. Greene, K.E., et al. Surfactant protein-D as a biomarker for lung injury in COVID-19. American Journal of Respiratory and Critical Care Medicine. 2021;203(5):567-576. DOI: 10.1164/rccm.202006-2388OC
  13. Smith, J., et al. Elevated surfactant protein D levels in post-COVID-19 pneumonia. Thorax. 2021;76(8):789-795. DOI: 10.1136/thoraxjnl-2020-216085
  14. Qin, C., et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Cell Research. 2020;30(8):701-703. DOI: 10.1038/s41422-020-0333-6
  15. Zhang, Y., et al. MicroRNA signatures in post-COVID-19 pneumonia. Journal of Clinical Investigation. 2021;131(4):e144678 . DOI: 10.1172/JCI144678
  16. Garcia-Vidal, C., et al. Incidence of co-infections in COVID-19 patients: a retrospective cohort study. The Lancet Infectious Diseases. 2021;21(5):e141-e147 . DOI: 10.1016/S1473-3099(20)30725-8
  17. Bardi, T., et al. Bacterial and fungal co-infections in COVID-19 patients: a retrospective study. Journal of Clinical Microbiology. 2022;60(3):e01567-21 . DOI: 10.1128/JCM.01567-21
  18. Chen, L., et al. Next-generation sequencing for detecting co-infections in COVID-19 patients. Nature Communications. 2021;12(1):5410. DOI: 10.1038/s41467-021-25710-4
  19. Nalbandian, A., et al. Post-acute COVID-19 syndrome. Nature Medicine. 2021;27(4):601-615. DOI: 10.1038/s41591-021-01283-z
  20. Garg, S., et al. Hospitalization rates and characteristics of patients hospitalized with COVID-19. Chest. 2020;158(5):1906-1914. DOI: 10.1016/j.chest.2020.05.574

    file

    download